These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 31382146)

  • 41. A systematic review of maternal TORCH serology as a screen for suspected fetal infection.
    Fitzpatrick D; Holmes NE; Hui L
    Prenat Diagn; 2022 Jan; 42(1):87-96. PubMed ID: 34893980
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rare detection of cytomegalovirus in severe fetal malformations in China.
    Lin X; Wang J; Wang Z; Ru T; Dai Y; Li J; Zhu X; Liu J; Ye X; Zhu B; Zhou YH; Hu Y
    J Clin Virol; 2016 Jun; 79():54-60. PubMed ID: 27089031
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Detection the serum IgM and IgG specific for TORCH in 1307 women in the period of pre-pregnancy and pregnancy].
    Qin W; Hu DC; Pang HL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Aug; 25(4):292-4. PubMed ID: 22097611
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prevalence of infectious agents in indigenous women of childbearing age in Venezuela].
    Monsalve-Castillo FM; Costa-León LA; Castellano ME; Suárez A; Atencio RJ
    Biomedica; 2012; 32(4):519-26. PubMed ID: 23715227
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Seroprevalence of TORCH infections in women of childbearing age in Croatia.
    Vilibic-Cavlek T; Ljubin-Sternak S; Ban M; Kolaric B; Sviben M; Mlinaric-Galinovic G
    J Matern Fetal Neonatal Med; 2011 Feb; 24(2):280-3. PubMed ID: 20476874
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TORCH Antibodies Among Pregnant Women and Their Newborns Receiving Care at Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
    Saajan AM; Nyindo M; Gidabayda JG; Abdallah MS; Jaffer SH; Mukhtar AG; Khatibu TM; Philemon R; Kinabo GD; Mmbaga BT
    East Afr Health Res J; 2017; 1(2):95-104. PubMed ID: 34308164
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibody prevalence to torch agents in pregnant women and relative risk of congenital infections in Italy (Liguria).
    Canessa A; Pantarotto F; Miletich F; Russo A; Gotta C; Bozzuffi PM; Ferrari G; Fiorelli A; Terragna A
    Biol Res Pregnancy Perinatol; 1987; 8(2 2D Half):84-8. PubMed ID: 2827796
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Toxoplasmosis in pregnancy: prevention, screening, and treatment.
    Paquet C; Yudin MH;
    J Obstet Gynaecol Can; 2013 Jan; 35(1):78-81. PubMed ID: 23343802
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ToRCH-screening in pediatric cataract revisited: A North Indian tertiary care centre study.
    Dasgupta S; Shakeel T; Roy RC
    Indian J Ophthalmol; 2020 May; 68(5):769-775. PubMed ID: 32317443
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of serum antibodies to TORCH among women before pregnancy or in the early period of pregnancy in Beijing.
    Li Z; Yan C; Liu P; Yan R; Feng Z
    Clin Chim Acta; 2009 May; 403(1-2):212-5. PubMed ID: 19302994
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intrauterine infections: a literature review.
    França CM; Mugayar LR
    Spec Care Dentist; 2004; 24(5):250-3. PubMed ID: 15552342
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of Syrian refugees on congenital TORCH infections screening in Turkey.
    Çoşkun B; Gülümser Ç; Çoşkun B; Artuk C; Karaşahin KE
    J Obstet Gynaecol Res; 2020 Jul; 46(7):1017-1024. PubMed ID: 32343041
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Preliminary study on ToRCH epidemic laws in Wuhan region].
    Gong Z; Luo L; Xiao H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Jun; 13(2):139-41. PubMed ID: 12569781
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Vestibular tests in infants with TORCH and after CNS infections].
    Zagólski O
    Przegl Lek; 2005; 62(8):769-71. PubMed ID: 16521494
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Term Newborn: Congenital Infections.
    Moodley A; Payton KSE
    Clin Perinatol; 2021 Aug; 48(3):485-511. PubMed ID: 34353577
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Analysis of serological findings and clinical manifestations of TORCH infections in newborns].
    Wang L; Li KH; Liu H; Liu JY; Li YJ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):283-4. PubMed ID: 15340579
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of viruses in the etiology of congenital malformations.
    Blattner RJ; Williamson AP; Heys FM
    Prog Med Virol; 1973; 15():1-41. PubMed ID: 4361322
    [No Abstract]   [Full Text] [Related]  

  • 58. Laboratory tests for diagnosis of TORCH infections.
    Kapil A; Broor S; Seth P
    Indian Pediatr; 1992 May; 29(5):643-9. PubMed ID: 1323532
    [No Abstract]   [Full Text] [Related]  

  • 59. A multifactorial analysis of the pregnancy outcomes in cytomegalovirus-infected women.
    Ding ZY; Xu F; Chen DZ; Meng XN; Xu TS; Lu MD; Zhuge HX
    Gynecol Obstet Invest; 2015; 80(2):106-12. PubMed ID: 25792174
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Congenital infections in Hong Kong: an overview of TORCH.
    Leung KKY; Hon KL; Yeung A; Leung AKC; Man E
    Hong Kong Med J; 2020 Apr; 26(2):127-138. PubMed ID: 32245914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.